7XY Stock Overview
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Swedencare AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr4.62 |
| 52 Week High | kr5.96 |
| 52 Week Low | kr2.72 |
| Beta | 1.02 |
| 1 Month Change | -14.68% |
| 3 Month Change | -18.09% |
| 1 Year Change | 42.02% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -56.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7XY | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -2.7% | 3.4% | 1.8% |
| 1Y | 42.0% | -25.9% | 4.2% |
Return vs Industry: 7XY exceeded the German Pharmaceuticals industry which returned -25.9% over the past year.
Return vs Market: 7XY exceeded the German Market which returned 4.2% over the past year.
Price Volatility
| 7XY volatility | |
|---|---|
| 7XY Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7XY has not had significant price volatility in the past 3 months.
Volatility Over Time: 7XY's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 552 | Hakan Lagerberg | www.swedencare.com |
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name.
Swedencare AB (publ) Fundamentals Summary
| 7XY fundamental statistics | |
|---|---|
| Market cap | €719.20m |
| Earnings (TTM) | €6.10m |
| Revenue (TTM) | €205.95m |
117.9x
P/E Ratio3.5x
P/S RatioIs 7XY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7XY income statement (TTM) | |
|---|---|
| Revenue | kr2.41b |
| Cost of Revenue | kr1.06b |
| Gross Profit | kr1.36b |
| Other Expenses | kr1.29b |
| Earnings | kr71.50m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 25, 2024
| Earnings per share (EPS) | 0.45 |
| Gross Margin | 56.28% |
| Net Profit Margin | 2.96% |
| Debt/Equity Ratio | 18.3% |
How did 7XY perform over the long term?
See historical performance and comparison